These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 31806085)

  • 1. The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities.
    Serafini RA; Pryce KD; Zachariou V
    Biol Psychiatry; 2020 Jan; 87(1):64-73. PubMed ID: 31806085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of pain, nociception, and analgesia by the brain reward center.
    Mitsi V; Zachariou V
    Neuroscience; 2016 Dec; 338():81-92. PubMed ID: 27189881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The affective dimension of pain as a risk factor for drug and alcohol addiction.
    LeBlanc DM; McGinn MA; Itoga CA; Edwards S
    Alcohol; 2015 Dec; 49(8):803-9. PubMed ID: 26008713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain and suicidality: insights from reward and addiction neuroscience.
    Elman I; Borsook D; Volkow ND
    Prog Neurobiol; 2013 Oct; 109():1-27. PubMed ID: 23827972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia disrupt mesolimbic reward circuitry in chronic pain.
    Taylor AM; Castonguay A; Taylor AJ; Murphy NP; Ghogha A; Cook C; Xue L; Olmstead MC; De Koninck Y; Evans CJ; Cahill CM
    J Neurosci; 2015 Jun; 35(22):8442-50. PubMed ID: 26041913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic pain.
    Mlost J; Wąsik A; Starowicz K
    Pharmacol Res; 2019 May; 143():40-47. PubMed ID: 30831242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution of neurotransmitters in the brain circuitry: Mesolimbic pathway and addiction.
    Ebrahimi MN; Banazadeh M; Alitaneh Z; Jaafari Suha A; Esmaeili A; Hasannejad-Asl B; Siahposht-Khachaki A; Hassanshahi A; Bagheri-Mohammadi S
    Physiol Behav; 2024 Oct; 284():114639. PubMed ID: 39004195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common Brain Mechanisms of Chronic Pain and Addiction.
    Elman I; Borsook D
    Neuron; 2016 Jan; 89(1):11-36. PubMed ID: 26748087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
    Blum K; Baron D; McLaughlin T; Gold MS
    J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Dopamine Signaling in Drug Addiction.
    Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
    Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticolimbic circuitry in the modulation of chronic pain and substance abuse.
    Taylor AMW
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Dec; 87(Pt B):263-268. PubMed ID: 28501595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain-induced alterations in the dynorphinergic system within the mesocorticolimbic pathway: Implication for alcohol addiction.
    Lorente JD; Cuitavi J; Campos-Jurado Y; Hipólito L
    J Neurosci Res; 2022 Jan; 100(1):165-182. PubMed ID: 32770601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the Manipulated Neurochemical Drive in Alcohol Addiction and Novel Therapeutic Advancements.
    Chouhan D; Uniyal A; Gadepalli A; Akhilesh ; Tiwari V; Agrawal S; Roy TK; Shaw S; Purohit N; Tiwari V
    ACS Chem Neurosci; 2020 May; 11(9):1210-1217. PubMed ID: 32243128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
    Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
    Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug addiction: An affective-cognitive disorder in need of a cure.
    Fattore L; Diana M
    Neurosci Biobehav Rev; 2016 Jun; 65():341-61. PubMed ID: 27095547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-type and projection-specific dopaminergic encoding of aversive stimuli in addiction.
    Thibeault KC; Kutlu MG; Sanders C; Calipari ES
    Brain Res; 2019 Jun; 1713():1-15. PubMed ID: 30580012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiologic processes in drug reward and addiction.
    Adinoff B
    Harv Rev Psychiatry; 2004; 12(6):305-20. PubMed ID: 15764467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors.
    Gupta A; Bowirrat A; Gomez LL; Baron D; Elman I; Giordano J; Jalali R; Badgaiyan RD; Modestino EJ; Gold MS; Braverman ER; Bajaj A; Blum K
    Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered neural oscillations and elevated dopamine levels in the reward pathway during alcohol relapse.
    Hadar R; Voget M; Vengeliene V; Haumesser JK; van Riesen C; Avchalumov Y; Spanagel R; Winter C
    Behav Brain Res; 2017 Jan; 316():131-135. PubMed ID: 27569184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?
    Gold MS; Baron D; Bowirrat A; Blum K
    J Neurol Sci; 2020 Nov; 418():117137. PubMed ID: 32957037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.